4-O-methylhonokiol prevents memory impairment in the tg2576 transgenic mice model of alzheimer's disease via regulation of β-secretase activity

Journal of Alzheimer's Disease

Volumn 29, Issue 3, 2012, Pages 677-690

  Lee, Young Jung ^a,b   Choi, Dong Young ^a,b   Lee, Yong Kyoung ^a,b   Lee, Yoot Mo ^a   Han, Sang Bae ^a,b   Kim, Young Hee ^c   Kim, Ki Ho ^c   Nam, Sang Yoon ^a   Lee, Beom Jun ^a   Kang, Jong Koo ^a   Yun, Young Won ^a   Oh, Ki Wan ^a   Hong, Jin Tae ^a,b  

^a Chungbuk National University   (South Korea)

^b Medical Research Center   (South Korea)

^c Bioland Ltd   (South Korea)

Author keywords

4 O methylhonokiol; Alzheimer's disease; neuroinflammation; oxidative stress; secretase

Indexed keywords

4 O METHYLHONOKIOL; AMYLOID BETA PROTEIN; BETA SECRETASE; GLUTATHIONE; INTERLEUKIN 1BETA; MAGNOLIA OFFICINALIS EXTRACT; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; INFLAMMATION; MEMORY DISORDER; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; TRANSGENIC MOUSE;

EID: 84859417407     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-2012-111835     Document Type: Article

References (73)

1. Evans DA, Funkenstein HH, Albert MS, Scherr PA, Cook NR, Chown MJ, Hebert LE, Hennekens CH, Taylor JO (1989) Prevalence of Alzheimer's disease ina community population of older persons. Higher than previously reported. JAMA 262, 2551-2556.
2. Weiner HL, Lemere CA, Maron R, Spooner ET, Grenfell TJ, Mori C, Issazadeh S, Hancock WW, Selkoe DJ (2000) Nasal administration of amyloid-beta peptide decreases cerebral amyloid burden inamouse modelofAlzheimer's disease. Ann Neurol 48, 567-579.
3. Price DL, Tanzi RE, Borchelt DR, Sisodia SS (1998) Alzheimer's disease: Genetic studies and transgenic models. Annu Rev Genet 32, 461-493. (Pubitemid 29045321)
4. Koudinov A, Kezlya E, Koudinova N, Berezov T (2009) Amyloid-beta, tau protein, and oxidative changes as a physiological compensatory mechanism to maintain CNS plasticity under Alzheimer's disease and other neurodegenerative conditions. J Alzheimers Dis 18, 381-400.
5. Golde TE, Dickson D, Hutton M (2006) Filling the gaps in the abeta cascade hypothesis of Alzheimer's disease. Curr Alzheimer Res 3, 421-430. (Pubitemid 46066421)
6. Selkoe DJ (2001) Alzheimer's disease: Genes, proteins, and therapy. Physiol Rev 81, 741-766. (Pubitemid 32267077)
7. Vassar R (2004) BACE1: The beta-secretase enzyme in Alzheimer's disease. J Mol Neurosci 23, 105-114.
8. Hussain I, Powell D, Howlett DR, Tew DG, Meek TD, Chapman C, Gloger IS, Murphy KE, Southan CD, Ryan DM, Smith TS, Simmons DL, Walsh FS, Dingwall C, Christie G (1999) Identification of a novel aspartic protease (Asp 2) as beta-secretase. Mol Cell Neurosci 14, 419-427. (Pubitemid 30026585)
9. Lin X, Koelsch G, Wu S, Downs D, Dashti A, Tang J (2000) Human aspartic protease memapsin 2 cleaves the beta-secretase site of beta-amyloid precursor protein. Proc Natl Acad Sci USA 97, 1456-1460. (Pubitemid 30118462)
10. Sinha S, Anderson JP, Barbour R, Basi GS, Caccavello R, Davis D, Doan M, Dovey HF, Frigon N, Hong J, Jacobson-Croak K, Jewett N, Keim P, Knops J, Lieberburg I, Power M, Tan H, Tatsuno G, Tung J, Schenk D, Seubert P, Suomen-saari SM, Wang S, Walker D, Zhao J, McConlogue L, John V (1999) Purification and cloning of amyloid precursor protein beta-secretase from human brain. Nature 402, 537-540.
11. Yan R, Bienkowski MJ, Shuck ME, Miao H, Tory MC, Pauley AM, Brashier JR, Stratman NC, Mathews WR, Buhl AE, Carter DB, Tomasselli AG, Parodi LA, Heinrikson RL, Gur-ney ME (1999) Membrane-anchored aspartyl protease with Alzheimer's disease beta-secretase activity. Nature 402, 533-537.
12. Cole SL, Vassar R (2007) The Alzheimer's disease beta-secretase enzyme, BACE1. Mol Neurodegener 2, 22.
13. Tamagno E, Bardini P, Obbili A, Vitali A, Borghi R, Zaccheo D, Pronzato MA, Danni O, Smith MA, Perry G, Tabaton M (2002) Oxidative stress increases expression and activity of BACE in NT2 neurons. Neurobiol Dis 10, 279-288. (Pubitemid 35217581)
14. Tamagno E, Parola M, Bardini P, Piccini A, Borghi R, Guglielmotto M, Santoro G, Davit A, Danni O, Smith MA, Perry G, Tabaton M (2005) Beta-site APP cleaving enzyme up-regulation induced by 4-hydroxynonenal is mediated by stress-activated protein kinases pathways. J Neurochem 92, 628-636. (Pubitemid 40189465)
15. Tong Y, Zhou W, Fung V, Christensen MA, Qing H, Sun X, Song W (2005) Oxidative stress potentiates BACE1 gene expression and Abeta generation. J Neural Transm 112, 455-469. (Pubitemid 40868054)
16. Aksenov M, Aksenova M, Butterfield DA, Markesbery WR (2000) Oxidative modification of creatine kinase BB in Alzheimer's disease brain. J Neurochem 74, 2520-2527. (Pubitemid 30314229)
17. Gibson GE, Huang HM (2005) Oxidative stress in Alzheimer's disease. Neurobiol Aging 26, 575-578. (Pubitemid 40228746)
18. Zhang X, Zhou K, Wang R, Cui J, Lipton SA, Liao FF, Xu H, Zhang YW (2007) Hypoxia-inducible factor 1alpha (HIF-1alpha)-mediated hypoxia increases BACE1 expression and beta-amyloid generation. J Biol Chem 282, 10873-10880. (Pubitemid 47100783)
19. Lin YR, Chen HH, Ko CH, Chan MH (2006) Neuroprotective activity of honokiol and magnolol in cerebellar granule cell damage. Eur J Pharmacol 537, 64-69.
20. Liou KT, Shen YC, Chen CF, Tsao CM, Tsai SK (2003) Honokiol protects rat brain from focal cerebral ischemia-reperfusion injury by inhibiting neutrophil infiltration and reactive oxygen species production. Brain Res 992, 159-166.
21. Frank B, Gupta S (2005) A review of antioxidants and Alzheimer's disease. Ann Clin Psychiatry 17, 269-286. (Pubitemid 41780250)
22. Rezai-Zadeh K, Arendash GW, Hou H, Fernandez F, Jensen M, Runfeldt M, Shytle RD, Tan J (2008) Green tea epigallocatechin-3-gallate (EGCG) reduces beta-amyloid mediated cognitive impairment and modulates tau pathology in Alzheimer transgenic mice. Brain Res 1214, 177-187.
23. Stackman RW, Eckenstein F, Frei B, Kulhanek D, Nowlin J, Quinn JF (2003) Prevention of age-related spatial memory deficitsinatransgenic mouse modelofAlzheimer'sdisease by chronic Ginkgo biloba treatment. Exp Neurol 184, 510-520. (Pubitemid 37444058)
24. LeBlanc AC, Papadopoulos M, Belair C, Chu W, Crosato M, Powell J, Goodyer CG (1997) Processing of amyloid precursor protein in human primary neuron and astrocyte cultures. J Neurochem 68, 1183-1190. (Pubitemid 27086224)
25. Casal C, Serratosa J, Tusell JM (2004) Effects of [beta]-AP peptides onactivationof the transcription factor NF-[kappa]B and in cell proliferation in glial cell cultures. Neuroscience Research 48, 315-323. (Pubitemid 38220949)
26. Perez JL, Carrero I, Gonzalo P, Arevalo-Serrano J, Sanz-Anquela JM, Ortega J, Rodriguez M, Gonzalo-Ruiz A (2010) Soluble oligomeric forms of beta-amyloid (Abeta) peptide stimulate Abeta production via astrogliosis in the rat brain. Exp Neurol 223, 410-421.
27. Constam DB, Philipp J, Malipiero UV, ten Dijke P, Schachner M, Fontana A (1992) Differential expression of transforming growth factor-beta 1,-beta 2, and-beta 3 by glioblas-toma cells, astrocytes, and microglia. J Immunol 148, 1404-1410.
28. Hu J, Akama KT, Krafft GA, Chromy BA, Van Eldik LJ (1998) Amyloid-beta peptide activates cultured astrocytes: Morphological alterations, cytokine induction and nitric oxide release. Brain Res 785, 195-206. (Pubitemid 28179382)
29. Johnstone M, Gearing AJ, Miller KM (1999) A central role for astrocytes in the inflammatory response to beta-amyloid; chemokines, cytokines and reactive oxygen species are produced. J Neuroimmunol 93, 182-193. (Pubitemid 29051564)
30. McGeer PL, McGeer EG (1995) The inflammatory response system of brain: Implications for therapy of Alzheimer and other neurodegenerative diseases. Brain Res Brain Res Rev 21, 195-218. (Pubitemid 26061873)
31. Blasko I, Apochal A, Boeck G, Hartmann T, Grubeck-Loebenstein B, Ransmayr G (2001) Ibuprofen decreases cytokine-induced amyloid beta production in neuronal cells. Neurobiol Dis 8, 1094-1101. (Pubitemid 34017102)
32. Blasko I, Veerhuis R, Stampfer-Kountchev M, Saurwein-Teissl M, Eikelenboom P, Grubeck-Loebenstein B (2000) Costimulatory effects of interferon-[gamma] and interleukin-1[beta] or tumor necrosis factor [alpha] on the synthesis of A[beta]1-40 and A[beta]1-42byhuman astrocytes. Neurobiol Dis 7, 682-689. (Pubitemid 32044292)
33. Cho HJ, Kim SK, Jin SM, Hwang EM, Kim YS, Huh K, Mook-Jung I (2007) IFN-gamma-induced BACE1 expression is mediatedby activationofJAK2 and ERK1/2 signaling pathways and direct binding of STAT1 to BACE1 promoter in astrocytes. Glia 55, 253-262. (Pubitemid 46225957)
34. Hong HS, Hwang EM, Sim HJ, Cho HJ, Boo JH, Oh SS, Kim SU, Mook-Jung I (2003) Interferon gamma stimulates beta-secretase expression and sAPPbeta production in astrocytes. Biochem Biophys Res Commun 307, 922-927. (Pubitemid 36871661)
35. Lim GP, Yang F, Chu T, Chen P, Beech W, Teter B, Tran T, Ubeda O, Ashe KH, Frautschy SA, Cole GM (2000) Ibuprofen suppresses plaque pathology and inflammation in a mouse model for Alzheimer's disease. J Neurosci 20, 5709-5714. (Pubitemid 30636898)
36. Yan Q, Zhang J, Liu H, Babu-Khan S, Vassar R, Biere AL, Citron M, Landreth G (2003) Anti-inflammatory drug therapy alters beta-amyloid processing and deposition in an animal model of Alzheimer's disease. J Neurosci 23, 7504-7509. (Pubitemid 37034066)
37. Kuribara H, Stavinoha WB, Maruyama Y (1998) Behavioural pharmacological characteristics of honokiol, an anxiolytic agent present in extracts of Magnolia bark, evaluated by an elevated plus-maze test in mice. J Pharm Pharmacol 50, 819-826. (Pubitemid 28379279)
38. Watanabe K, Watanabe H, Goto Y, Yamaguchi M, Yamamoto N, Hagino K (1983) Pharmacological Properties of Magnolol and Honokiol Extracted from Magnolia officinalis: Central Depressant Effects. Planta Med 49, 103-108. (Pubitemid 14239052)
39. Lin YR, Chen HH, Ko CH, Chan MH (2007) Effects of hon-okiol and magnolol on acute and inflammatory pain models in mice. Life Sci 81, 1071-1078.
40. Munroe ME, Arbiser JL, Bishop GA (2007) Honokiol, a natural plant product, inhibits inflammatory signals and alleviates inflammatory arthritis. J Immunol 179, 753-763.
41. Zhou HY, Shin EM, Guo LY, Youn UJ, Bae K, Kang SS, Zou LB, Kim YS (2008) Anti-inflammatory activity of 4-methoxyhonokiol is a function of the inhibition of iNOS and COX-2 expression in RAW 264.7 macrophages via NF-kappaB, JNK and p38 MAPK inactivation. Eur J Pharmacol 586, 340-349.
42. Chen CL, Chang PL, Lee SS, Peng FC, Kuo CH, Chang HT (2007) Analysis of magnolol and honokiol in biological fluids by capillary zone electrophoresis. J Chromatogr A 1142, 240-244.
43. Dikalov S, Losik T, Arbiser JL (2008) Honokiol is a potent scavenger of superoxide and peroxyl radicals. Biochem Pharmacol 76, 589-596.
44. Fujita S, Taira J (1994) Biphenyl compounds are hydroxyl radical scavengers: Their effective inhibition for UV-induced mutation in Salmonella typhimurium TA102. Free Radic Biol Med 17, 273-277. (Pubitemid 24269680)
45. Oh JH, Kang LL, Ban JO, Kim YH, Kim KH, Han SB, Hong JT (2009) Anti-inflammatory effect of 4-O-methylhonokiol, a novel compound isolated from Magnolia officinalis through inhibition of NF-kappaB. Chem Biol Interact 180, 506-514.
46. Lee JW, Lee YK, Lee BJ, Nam SY, Lee SI, Kim YH, Kim KH, Oh KW, Hong JT (2010) Inhibitory effect of ethanol extract of Magnolia officinalis and 4-O-methylhonokiol on memory impairment and neuronal toxicity induced by beta-amyloid. Pharmacol Biochem Behav 95, 31-40.
47. Lee YK, Choi IS, Kim YH, Kim KH, Nam SY, Yun YW, Lee MS, Oh KW, Hong JT (2009) Neurite outgrowth effect of 4-O-methylhonokiol by induction of neurotrophic factors through ERK activation. Neurochem Res 34, 2251-2260.
48. Lee YK, Yuk DY, Kim TI, Kim YH, Kim KT, Kim KH, Lee BJ, Nam SY, Hong JT (2009) Protective effect of the ethanol extract of Magnolia officinalis and 4-O-methylhonokiol on scopolamine-induced memory impairment and the inhibition of acetylcholinesterase activity. J Nat Med 63, 274-282.
49. Lee YK, Choi IS, Ban JO, Lee HJ, Lee US, Han SB, Jung JK, Kim YH, Kim KH, Oh KW, Hong JT (2011) 4-O-methylhonokiol attenuated beta-amyloid-induced memory impairment through reduction of oxidative damages via inactivation of p38 MAP kinase. J Nutr Biochem 22, 476-486.
50. Lee YJ, Choi IS, Park MH, Lee YM, Song JK, Kim YH, Kim KH, Hwang DY, Jeong JH, Yun YP, Oh KW, Jung JK, Han SB, Hong JT (2011) 4-O-Methylhonokiol attenuates memory impairment in presenilin 2 mutant mice through reduction of oxidative damage and inactivation of astrocytes and the ERK pathway. Free Radic Biol Med 50, 66-77.
51. Choi IS, Lee YJ, Choi DY, Lee YK, Lee YH, Kim KH, Kim YH, Jeon YH, Kim EH, Han SB, Jung JK, Yun YP, Oh KW, Hwang DY, Hong JT (2011) 4-O-methylhonokiol attenuated memory impairment through modulation ofoxidative damage of enzymes involving amyloid-beta generation and accumulation in a mouse model of alzheimer's disease. J Alzheimers Dis 27, 127-141.
52. Hsiao K, Chapman P, Nilsen S, Eckman C, Harigaya Y, Younkin S, Yang F, Cole G (1996) Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science 274, 99-102. (Pubitemid 26332733)
53. Irizarry MC, McNamara M, Fedorchak K, Hsiao K, Hyman BT (1997) APPSwtransgenic mice develop age-relatedAbeta deposits and neuropil abnormalities, but no neuronal loss in CA1. J Neuropathol Exp Neurol 56, 965-973. (Pubitemid 27386126)
54. Westerman MA, Cooper-Blacketer D, Mariash A, Kotilinek L, Kawarabayashi T, Younkin LH, Carlson GA, Younkin SG, Ashe KH (2002) The relationship between Abeta and memory in the Tg2576 mouse model of Alzheimer's disease. J Neurosci 22, 1858-1867. (Pubitemid 35386304)
55. Jantzen PT, Connor KE, DiCarlo G, Wenk GL, Wallace JL, Rojiani AM, Coppola D, Morgan D, Gordon MN (2002) Microglial activation and beta-amyloid deposit reduction caused by a nitric oxide-releasing nonsteroidal anti-inflammatory drug in amyloid precursor protein plus presenilin-1 transgenic mice. J Neurosci 22, 2246-2254. (Pubitemid 35386524)
56. Lim GP, Chu T, Yang F, Beech W, Frautschy SA, Cole GM (2001) The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse. J Neurosci 21, 8370-8377. (Pubitemid 33051435)
57. Matsuoka Y, Picciano M, La Francois J, Duff K (2001) Fib-rillar beta-amyloid evokes oxidative damage in a transgenic mouse model of Alzheimer's disease. Neuroscience 104, 609-613. (Pubitemid 32607413)
58. Yao Y, Chinnici C, Tang H, Trojanowski JQ, Lee VM, Pratico D (2004) Brain inflammation and oxidative stress in a trans-genic mouse model of Alzheimer-like brain amyloidosis. J Neuroinflammation 1, 21.
59. Morris R (1984) Developments of a water-maze procedure for studying spatial learning in the rat. J Neurosci Methods 11, 47-60. (Pubitemid 14088970)
60. Wilcock DM, Gordon MN, Morgan D (2006) Quantification of cerebral amyloid angiopathy and parenchymal amyloid plaques with Congo red histochemical stain. Nat Protoc 1, 1591-1595.
61. Lee JW, Lee YK, Yuk DY, Choi DY, Ban SB, Oh KW, Hong JT (2008) Neuro-inflammation induced by lipopolysaccha-ride causes cognitive impairment through enhancement of beta-amyloid generation. J Neuroinflammation 5, 37.
62. Selkoe DJ (1998) The cell biology of beta-amyloid precursor protein and presenilininAlzheimer's disease. Trends Cell Biol 8, 447-453.
63. Reddy VP, Zhu X, Perry G, Smith MA (2009) Oxidative stress in diabetes and Alzheimer's disease. J Alzheimers Dis 16, 763-774.
64. Sultana R, Perluigi M, Butterfield DA (2009) Oxidatively modified proteins in Alzheimer's disease (AD), mild cognitive impairment and animal models of AD: Role of Abeta in pathogenesis. Acta Neuropathol 118, 131-150.
65. Smith MA, Hirai K, Hsiao K, Pappolla MA, Harris PL, Sied-lak SL, Tabaton M, Perry G (1998) Amyloid-beta deposition in Alzheimer transgenic mice is associated with oxidative stress. J Neurochem 70, 2212-2215. (Pubitemid 28207848)
66. Borghi R, Patriarca S, Traverso N, Piccini A, Storace D, Garuti A, Cirmena G, Odetti P, Tabaton M (2007) The increased activity of BACE1 correlates with oxidative stress in Alzheimer's disease. Neurobiol Aging 28, 1009-1014. (Pubitemid 46635907)
67. Di Bona D, Scapagnini G, Candore G, Castiglia L, Colonna-Romano G, Duro G, Nuzzo D, Iemolo F, Lio D, Pellicano M, Scafidi V, Caruso C, Vasto S (2010) Immune-inflammatory responses and oxidative stress in Alzheimer's disease: Therapeutic implications. Curr Pharm Des 16, 684-691.
68. Galimberti D, Scarpini E (2011) Inflammation and oxidative damage in Alzheimer's disease: Friend or foe? Front Biosci (Schol Ed) 3, 252-266.
69. Patel JR, Brewer GJ (2003) Age-related changes in neuronal glucose uptake in response to glutamate and beta-amyloid. J Neurosci Res 72, 527-536. (Pubitemid 36523427)
70. Yamamoto M, Kiyota T, Horiba M, Buescher JL, Walsh SM, Gendelman HE, Ikezu T (2007) Interferon-gamma and tumor necrosis factor-alpha regulate amyloid-beta plaque deposition and beta-secretase expression in Swedish mutant APP transgenic mice. Am J Pathol 170, 680-692. (Pubitemid 47339404)
71. Lin YR, Chen HH, Ko CH, Chan MH (2005) Differential inhibitory effects of honokiol and magnolol on excitatory amino acid-evoked cation signals and NMDA-induced seizures. Neuropharmacology 49, 542-550.
72. Chiu JH, Ho CT, Wei YH, Lui WY, Hong CY (1997) In vitro and in vivo protective effect of honokiol on rat liver from peroxidative injury. Life Sci 61, 1961-1971.
73. Seo JJ, Lee SH, Lee YS, Kwon BM, Ma Y, Hwang BY, Hong JT, Oh KW (2007) Anxiolytic-like effects of obovatol isolated from Magnolia obovata: Involvement of GABA/benzodiazepine receptors complex. Prog Neuropsy-chopharmacol Biol Psychiatry 31, 1363-1369. (Pubitemid 47302547)